A Nonlinear Relation between Body Mass Index and Long-Term Poststroke Functional Outcome—The Importance of Insulin Resistance, Inflammation, and Insulin-like Growth Factor-Binding Protein-1

Gustaf Gadd,Daniel Åberg,Alexander Wall,Henrik Zetterberg,Kaj Blennow,Katarina Jood,Christina Jern,Jörgen Isgaard,Johan Svensson,N. David Åberg
DOI: https://doi.org/10.3390/ijms25094931
IF: 5.6
2024-05-01
International Journal of Molecular Sciences
Abstract:Both high serum insulin-like growth factor-binding protein-1 (s-IGFBP-1) and insulin resistance (IR) are associated with poor functional outcome poststroke, whereas overweight body mass index (BMI; 25–30) is related to fewer deaths and favorable functional outcome in a phenomenon labeled "the obesity paradox". Furthermore, IGFBP-1 is inversely related to BMI, in contrast to the linear relation between IR and BMI. Here, we investigated s-IGFBP-1 and IR concerning BMI and 7-year poststroke functional outcome. We included 451 stroke patients from the Sahlgrenska Study on Ischemic Stroke (SAHLSIS) with baseline measurements of s-IGFBP1, homeostasis model assessment of IR (HOMA-IR), BMI (categories: normal-weight (8.5–25), overweight (25–30), and obesity (>30)), and high-sensitivity C-reactive protein (hs-CRP) as a measure of general inflammation. Associations with poor functional outcome (modified Rankin scale [mRS] score: 3–6) after 7 years were evaluated using multivariable binary logistic regression, with overweight as reference due to the nonlinear relationship. Both normal-weight (odds-ratio [OR] 2.32, 95% confidence interval [CI] 1.30–4.14) and obese (OR 2.25, 95% CI 1.08–4.71) patients had an increased risk of poor functional outcome, driven by deaths only in the normal-weight. In normal-weight, s-IGFBP-1 modestly attenuated (8.3%) this association. In the obese, the association was instead attenuated by HOMA-IR (22.4%) and hs-CRP (10.4%). Thus, a nonlinear relation between BMI and poor 7-year functional outcome was differently attenuated in the normal-weight and the obese.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the non - linear relationship between body mass index (BMI) and long - term functional outcomes after stroke, especially to study the roles of insulin resistance (IR), inflammation and insulin - like growth factor - binding protein - 1 (IGFBP - 1) in this relationship. Specifically, the paper focuses on the obesity paradox (i.e., the phenomenon that overweight or obese patients may have better survival rates and recovery after stroke than normal - weight patients), and attempts to explain this phenomenon by analyzing these factors. The main objectives of the paper include: 1. **Explore the non - linear relationship between BMI and functional outcomes 7 years after stroke**: The study found that there is a non - linear relationship between BMI and functional outcomes 7 years after stroke, among which overweight patients have the best prognosis, while normal - weight and obese patients have poorer prognoses. 2. **Evaluate the roles of insulin resistance (IR), inflammation (measured by high - sensitivity C - reactive protein hs - CRP) and IGFBP - 1 in this relationship**: The study found that the impacts of these factors are different in different BMI categories, especially in normal - weight and obese patients, the contributions of these factors to the prognosis are different. 3. **Explain the obesity paradox**: By analyzing the above - mentioned factors, the study attempts to explain why overweight patients have a better prognosis after stroke instead. Through multivariate binary logistic regression analysis, the paper explored the relationships between BMI, insulin resistance, inflammation and IGFBP - 1 levels and functional outcomes 7 years after stroke, and drew the following conclusions: - The 7 - year functional outcomes of normal - weight patients (BMI 18.5–25) and obese patients (BMI > 30) are poorer, while the functional outcomes of overweight patients (BMI 25–30) are better. - The roles of insulin resistance and inflammation are more significant in obese patients, while the role of IGFBP - 1 is more important in normal - weight patients. Through these analyses, the paper aims to provide a new perspective for understanding the obesity paradox and provide a scientific basis for clinical treatment and prevention of post - stroke dysfunction.